Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lynsay L. Waller"'
Autor:
Lynsay L. Waller, Vincent A. Memoli, William R. Voelzke, R. Matthew Graham, Catherine B. Swift, W. Jeffrey Petty, James J. Urbanic, Victor A. Varela, Konstantin H. Dragnev
Publikováno v:
Lung Cancer. 74:384-391
Background Prior studies highlighted cyclin D1 as a key biomarker of response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. This study builds on prior work by examining the roles of cyclin D1, cyclin D3, and cyclin E in media
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65605a436c60244257d72ed18234ea26
https://doi.org/10.1016/j.lungcan.2011.04.004
https://doi.org/10.1016/j.lungcan.2011.04.004
Autor:
Antonius A. Miller, Nathan P. Streer, Travis Dotson, Jimmy Ruiz, William J. Petty, Lynsay L. Waller, Jennifer Laudadio
Publikováno v:
D98. NOVEL MECHANISMS OF TUMOR PROMOTION AND MOLECULAR TARGETED THERAPY IN LUNG CANCER.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ae2b2bcff565ff82447c5337bd099a8
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6523
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6523
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 67(1)
Erlotinib is active for unselected patients with advanced non-small cell lung cancer. Patients who smoke, however, are less likely to respond and less likely to experience toxicity. These patients rapidly metabolize erlotinib and experience lower dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b623d908c43a505a963d1ce0c914fcaf
https://pubmed.ncbi.nlm.nih.gov/19762110
https://pubmed.ncbi.nlm.nih.gov/19762110